Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

We’ve Officially Got A Fourth Vaccine, So Here’s Everything You Need To Know About Novavax

Say hello to Ms Novavax!

Pedestrian.tv

5 Stocks To Watch For February 8, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects Pfizer Inc. (NYSE: PFE) to report quarterly earnings at $0.87 per share on revenue of $24.20 billion before the opening bell. Pfizer shares rose 1.7% to $54.10 in after-hours trading.

Benzinga

Pfizer set for record vaccine revenue as world’s dose-sharing initiative runs out of cash

Pfizer’s Covid vaccine has become one of the most lucrative drugs in history

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

Earnings Scheduled For February 8, 2022

Companies Reporting Before The Bell • Pfizer (NYSE:PFE) is likely to report quarterly earnings at $0.87 per share on revenue of $24.20 billion.

Benzinga

Ofgem admits failings over energy regulation, and warns Ukraine conflict would push bills higher – as it happened

Rolling coverage of the latest economic and financial news

The Guardian - UK

Covid live: Italy and Spain to ease mask mandate; UK records 66,183 new cases – as it happened

Italy and Spain relax rules on wearing masks in outdoor spaces; UK records 314 Covid-related deaths

The Guardian - AU

What's the difference in protection against Omicron between 2 doses and 3 doses of vaccine?

Australian Health Minister Greg Hunt said last week he expects the Australian Technical Advisory Group on Immunisation (ATAGI) to change the definition of “fully vaccinated” to three doses instead of two.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

A Preview Of Pfizer's Earnings

Pfizer (NYSE:PFE) is set to give its latest quarterly earnings report on Tuesday, 2022-02-08. Here's what investors need to know before the announcement. Analysts estimate that Pfizer will likely report an Earnings Per Share (EPS) of $7.85.

Benzinga

Kids' vaccines create a new dilemma for federal officials

They'll have to decide whether to authorize shots for small children with incomplete data.

Axios

Can Sinovac protect Indonesia from the Omicron wave?

Most of the vaccinated in the archipelago have been given the Sinovac shot.

Al Jazeera

Hawaii, New York enact new congressional district maps; Pennsylvania Supreme Court assumes control over redistricting

Our weekly summary of federal news highlights redistricting updates in Hawaii, New York, and Pennsylvania, and the FDA approving the Moderna COVID-19 vaccine. Read all about it in this week’s edition of the Federal Tap.

Ballotpedia

Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward

Valneva SE (NASDAQ: VALN) and Pfizer Inc (NYSE: PFE) have

Benzinga

The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

16-17 year olds can now get their COVID boosters. Why not younger children?

Adolescents aged 16-17 are now eligible to receive their Pfizer vaccine booster, following the recommendation earlier this week from the Australian Technical Advisory Group on Immunisation (ATAGI).

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

The Independent UK

A different COVID-19 vaccine debate: Do we need new ones?

COVID-19 vaccines still are saving untold lives, but omicron's easy spread has many wondering if they will need boosters every few months or even a new kind of shot altogether

Axios

Pfizer goes from villain to hero

The company lands fourth on Fortune magazine’s list of most admired companies

The Guardian - AU

Albanese demands Colbeck ‘resign today’ as nation records 82 Covid deaths – as it happened

This blog is now closed

ABC News

ATAGI approves Pfizer COVID-19 vaccine booster shots for 16 and 17-year-olds

Australia's vaccine advisory body approves a third dose of Pfizer's COVID-19 vaccine for 16 and 17-year-olds.

Get all your
news in one place.

100's of premium titles.
One news app.

Los Angeles Times

Johnson & Johnson recipients can get third COVID shot in San Francisco

SAN FRANCISCO — San Francisco health officials are allowing people who originally got the Johnson & Johnson COVID-19 vaccine to get a second booster shot — which would give them access to the same number of doses currently available to recipients of Pfizer-BioNTech or Moderna.

The Independent UK

EXPLAINER: COVID vaccines for kids under 5: What's next?

COVID-19 vaccines for kids under 5 may be available in the U.S. as early as March, but there are several hurdles still to clear

Tribune News Service

Q&A: What to know about Pfizer’s COVID-19 vaccine for kids under age 5

The Food and Drug Administration said Tuesday it will consider authorizing Pfizer’s COVID-19 vaccine for kids as young as 6 months, opening the door to immunizing some 23 million American children for whom vaccines haven’t yet been available.

The Independent UK

France to start using Pfizer's COVID-19 drug, first in EU

France says it will start administering Pfizer’s coronavirus antiviral drug this week, the first pill for treating COVID-19 approved in the 27-nation EU

Benzinga

FDA Asks Pfizer - BioNTech To Submit For COVID-19 Vaccine Emergency Use Nod For Youngest Children

Pfizer Inc (NYSE: PFE) and its partner BioNTech SE (NASDAQ: BNTX) have

The Guardian - US

Pfizer seeks US authorization of Covid vaccine for children under five

FDA decision could come within weeks but big obstacles remain to getting all children inoculated

Asharq Al-Awsat

Pfizer Seeks US Approval of Covid Vaccine for Children under 5

Pfizer and BioNTech said Tuesday they are seeking emergency authorization from US health regulators for use of their Covid vaccine for children aged over six months and under five years. If the Food and Drug Administration (FDA) authorizes the two-shot regimen, it will become the first Covid vaccine available to…

1 … 68 69 70 71

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Office for National Statistics

Bureau of Meteorology

527 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.